GGrantIndex
← Search

IDENTIFYING THERAPEUTIC VULNERABILITIES OF BONE MARROW-DRIVEN RECURRENCE OF ER+ BREAST CANCER

$1,169,999FY2022Department of the ArmyDOD

Regents Of The University Of Michigan

Investigators

View source on USAspending →
IDENTIFYING THERAPEUTIC VULNERABILITIES OF BONE MARROW-DRIVEN RECURRENCE OF ER+ BREAST CANCER · GrantIndex